Table 1 Correlations between metabolism signature and clinicopathological parameters of 530 patients in TCGA-ccRCC cohort.
Category | Cases (n = 530) | Metabolism signature | ||
|---|---|---|---|---|
Low risk (n = 265) | High risk (n = 265) | |||
Status | Alive | 364 (68.68%) | 218 (59.89%) | 146 (40.11%) |
Death | 166 (31.32%) | 47 (28.31%) | 119 (71.69%) | |
Age | ≤ 65 | 348 (65.66%) | 177 (50.86%) | 171 (49.14%) |
> 65 | 182 (34.34%) | 88 (48.35%) | 94 (51.65%) | |
Gender | Female | 186 (35.09%) | 112 (60.22%) | 74 (39.78%) |
Male | 344 (64.91%) | 153 (44.48%) | 191 (55.52%) | |
Grade | G1 | 14 (2.64%) | 11 (78.57%) | 3 (21.43%) |
G2 | 227 (42.83%) | 145 (63.88%) | 82 (36.12%) | |
G3 | 206 (38.87%) | 95 (46.12%) | 111 (53.88%) | |
G4 | 75 (14.15%) | 8 (10.67%) | 67 (89.33%) | |
Unknown | 8 (1.51%) | |||
Stage | Stage I | 265 (50.00%) | 171 (64.53%) | 94 (35.47%) |
Stage II | 57 (10.75%) | 29 (50.88%) | 28 (49.12%) | |
Stage III | 123 (23.21%) | 44 (35.77%) | 79 (64.23%) | |
Stage IV | 82 (15.47%) | 20 (24.39%) | 62 (75.61%) | |
Unknown | 3 (0.57%) | |||
T | T1 | 271 (51.13%) | 173 (63.84%) | 98 (36.16%) |
T2 | 69 (13.02%) | 30 (43.48%) | 39 (56.52%) | |
T3 | 179 (33.77%) | 60 (33.52%) | 119 (66.48%) | |
T4 | 11 (2.08%) | 2 (18.18%) | 9 (81.82%) | |
M | M0 | 420 (79.25%) | 227 (54.05%) | 193 (45.95%) |
M1 | 78 (14.72%) | 19 (24.36%) | 59 (75.64%) | |
Unknown | 32 (6.04%) | |||
N | N0 | 239 (45.09%) | 121 (50.63%) | 118 (49.37%) |
N1 | 16 (3.02%) | 3 (18.75%) | 13 (81.25%) | |
Unknown | 275 (51.89%) | |||
